From the bench.

BPC-157 10mg vials sat firmly in the tray; print and seals looked fine.

Interior was tidy and the vials were easy to sort by label text.

Last check: all research vial names on my list present, none mystery items. Done.

BPC-157 10mg print sharp in daylight.

GHK-Cu 50mg labels stayed flat. No bubbles under the film.

Tape bridged the flaps cleanly and the inner presentation looked orderly.

Weighed the closed carton on a kitchen scale; felt consistent with glass inside.

GHK-Cu 50mg sat still in the insert; no rattling when carried.

Retatrutide 10mg foam kept space between the vials. Steady.

Tirzepatide 10mg sleeve had a small inspection tick mark in pencil.

Underneath, the vials lay flat in the insert with readable labels.

BPC-157 10mg came in a plain sturdy carton. Looked okay.

BPC-157 10mg had the product name on each vial. Clear enough.

Short carton, dense foam. Little wasted space around the glass.

Retatrutide 10mg seals and text were easy to verify on arrival.

TB-500 10mg count on the packing list equal to the number of vials in the tray.

Compared the printed strength on BPC-157 10mg to the product line — same numbers.

Mixed GHK-Cu 50mg with another research vial in one shipper; each sleeve was marked, so no mix-up.

The vials sat still in the foam and the labels were easy to read.

Quick note: arrived, labelled, sealed — that's all the check needed.